Cervical cytology with a diagnosis of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a follow-up study with corresponding histology and significance of predicting dysplasia by human papillomavirus (HPV) DNA testing
- 330 Downloads
- 6 Citations
Abstract
Objectives
To evaluate the clinical significance of “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion” ASC-H by comparing the original cytologic findings with follow-up tissue biopsies, and its association with high-risk HPV.
Methods
A total of 235,518 ThinPrep Pap tests were performed at our institution from January 2008 through December 2010, but only 727 (0.3 %) of these cases were diagnosed as ASC-H.
Results
Of the 309 cases diagnosed as ASC-H on cytology for which follow-up histologic material was available, 120 (38.8 %) were definitively diagnosed as high-grade dysplasia (CIN 2/3) and 75 (24.2 %) showed features of low-grade dysplasia (CIN 1). We observed that the incidence of dysplasia in patients less than 30 years of age was 73.4 % (113/154) and 48.3 % (14/29) in patients greater than 49 years of age (p = 0.001). There were 71 cases for which high-risk HPV DNA testing was conducted. HPV DNA was found to be positive in 41 of the dysplastic cases (CIN 1 = 18 cases and CIN 2/3 = 23) and negative in six of the dysplastic cases (CIN1 = 2 and CIN2/3 = 4).
Conclusion
We conclude that cases diagnosed as ASC-H should be followed-up with caution as they are strongly associated with dysplasia of any grade (63.1 %), especially high-grade dysplasia (38.8 %). Reflex HPV DNA testing is an important predictor of dysplasia with a positive predictive value of 87.2 % in our study.
Keywords
Atypical squamous cells High grade Cervical biopsy HPV Follow-upNotes
Conflict of interest
We declare that we have no conflict of interest.
References
- 1.Sherman ME, Abdul-Karim FW, Berek JS, Powers CN, Sidawy MK, Tabbara SO (2004) Atypical squamous cells. In: Solomon D, Nayar R (eds) The Bethesda System for Reporting Cervical Cytology, 2nd edn. Springer, New York, pp 67–68CrossRefGoogle Scholar
- 2.Galliano GE, Moatamed NA, Lee S, Salami N, Apple SK (2011) Reflex high risk HPV testing in atypical squamous cells, cannot exclude high grade intraepithelial lesion: a large institution’s experience with the significance of this often ordered test. Acta Cytol 55:167–172PubMedCrossRefGoogle Scholar
- 3.Alli PM, Ali SZ (2003) Atypical squamous cells of undetermined significance—rule out high-grade squamous intraepithelial lesion: cytopathologic characteristics and clinical correlates. Diagn Cytopathol 28:308–312PubMedCrossRefGoogle Scholar
- 4.Selvaggi SM (2003) Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant? Diagn Cytopathol 29:38–41PubMedCrossRefGoogle Scholar
- 5.Louro AP, Roberson J, Eltoum I, Chhieng DC (2003) Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. A follow-up study of conventional and liquid-based preparations in a high-risk population. Am J Clin Pathol 120:392–397PubMedCrossRefGoogle Scholar
- 6.Mokhtar GA, Delatour NL, Assiri AH, Gilliatt MA, Senterman M, Islam S (2008) Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: cytohistologic correlation study with diagnostic pitfalls. Acta Cytol 52:169–177PubMedCrossRefGoogle Scholar
- 7.McHale MT, Souther J, Elkas JC, Monk BJ, Harrison TA (2007) Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant? J Low Genit Tract Dis 11:86–89PubMedCrossRefGoogle Scholar
- 8.Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) For the 2006 American Society for Colposcopy and Cervical Pathology (ASCCP)-sponsored consensus conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197:346–355PubMedCrossRefGoogle Scholar
- 9.Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 11:201–222PubMedCrossRefGoogle Scholar
- 10.Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N (2008) Atypical squamous cells, cannot exclude a high-grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive-use patients. Cancer 114:481–488PubMedCrossRefGoogle Scholar
- 11.Kietpeerakool C, Srisomboon J, Tantipalakorn C, Suprasert P, Khunamornpong S, Nimmanhaeminda K, Siriaunkgul S (2008) Underlying pathology of women with “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion” smears, in a region with a high incidence of cervical cancer. J Obstet Gynaecol Res 34:204–209PubMedCrossRefGoogle Scholar
- 12.Bandyopadhyay S, Austin RM, Dabbs D, Zhao C (2008) Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med 132:1874–1881PubMedGoogle Scholar
- 13.Sherman ME, Castle PE, Solomon D (2006) Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. Cancer 108:298–305PubMedCrossRefGoogle Scholar
- 14.Reid-Nicholson M, Gatscha RM, Riedel ER, Lin O (2007) Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? Diagn Cytopathol 35:1–5PubMedCrossRefGoogle Scholar
- 15.Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K (2006) Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 106:1054–1064PubMedCrossRefGoogle Scholar
- 16.Gupta S, Sodhani P, Chachra KL, Singh V, Sehgal A (2007) Outcome of “atypical squamous cells” in a cervical cytology screening program: implications for follow up in resource limited settings. Diagn Cytopathol 35:677–680PubMedCrossRefGoogle Scholar